Association of second-line antidiabetic medications with cardiovascular events among insured adults with type 2 diabetes
MJ O'Brien, SL Karam, A Wallia, RH Kang… - JAMA network …, 2018 - jamanetwork.com
Importance Understanding cardiovascular outcomes of initiating second-line antidiabetic
medications (ADMs) may help inform treatment decisions after metformin alone is not …
medications (ADMs) may help inform treatment decisions after metformin alone is not …
The state of diabetes prevention policy in the USA following the Affordable Care Act
JN Konchak, MR Moran, MJ O'Brien, NR Kandula… - Current diabetes …, 2016 - Springer
Type 2 diabetes is a major public health problem in the USA, affecting over 12% of American
adults and imposing considerable health and economic burden on individuals and society …
adults and imposing considerable health and economic burden on individuals and society …
Patient perceptions about prediabetes and preferences for diabetes prevention
MJ O'Brien, MR Moran, JW Tang… - The Diabetes …, 2016 - journals.sagepub.com
Purpose The purpose of this study was to explore how adults with prediabetes perceive their
risk of developing diabetes and examine their preferences for evidence-based treatment …
risk of developing diabetes and examine their preferences for evidence-based treatment …
Preventing diabetes in primary care: providers' perspectives about diagnosing and treating prediabetes
NR Kandula, MR Moran, JW Tang… - Clinical Diabetes, 2018 - Am Diabetes Assoc
IN BRIEF Offering patient-centered care to prevent diabetes will require collaborative
decision-making between patients with prediabetes and their health care providers. From …
decision-making between patients with prediabetes and their health care providers. From …
Correlates of second-line type 2 diabetes medication selection in the USA
RT Ackermann, A Wallia, MJ O'brien, R Kang… - BMJ Open Diabetes …, 2017 - drc.bmj.com
Objective Past research provides insufficient evidence to inform second-line diabetes
medication prescribing when metformin is no longer sufficient. We evaluated patient …
medication prescribing when metformin is no longer sufficient. We evaluated patient …
Radiation oncologists' role in end-of-life care: A perspective from medical oncologists
JP Gross, JM Kruser, MR Moran, K Kaiser… - Practical Radiation …, 2019 - Elsevier
Purpose Multidisciplinary communication and collaboration are key to planning and
delivering end-of-life care for patients with advanced and metastatic cancer. We sought to …
delivering end-of-life care for patients with advanced and metastatic cancer. We sought to …
The Comparative Cardiovascular Effectiveness of Six Antidiabetic Medications among Insured Adults with Type 2 Diabetes
M O'BRIEN, SL Karam, A Wallia, R Kang, AJ Cooper… - Diabetes, 2018 - Am Diabetes Assoc
This retrospective cohort study compared the effectiveness of six antidiabetic medication
(ADM) classes on major adverse cardiovascular events. Using nationwide US administrative …
(ADM) classes on major adverse cardiovascular events. Using nationwide US administrative …
[CITATION][C] ENGAGING BREAST CANCER SURVIVORS IN DEVELOPING A TECHNOLOGY-SUPPORTED PHYSICAL ACTIVITY INTERVENTION: THE FIT2THRIVE …
S Phillips, G Lloyd, MR Moran… - ANNALS OF …, 2017 - … 233 SPRING ST, NEW YORK, NY …